Comparable stake leader
Bain Charger Holdings, L.P.
SEC ownership of KESTRA MEDICAL TECHNOLOGIES, LTD.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001877184.
Disclosed value leader
Jeffrey Lawrence Schwartz
Comparable rows
4/50
Latest evidence
30 Sep 2026
- Public ticker
- KMTS on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Bain Charger Holdings, L.P.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
4 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Bain Charger Holdings, L.P.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001877184
- Issuer location
- Kirkland, WA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of KESTRA MEDICAL TECHNOLOGIES, LTD. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bain Charger Holdings, L.P.
Disclosed value leader
Jeffrey Lawrence Schwartz
Comparable rows
4/50
Latest evidence
30 Sep 2026
13D/G
13F
3/4/5
Lead comparable stake: 43%
46 rows are not safely comparable across share classes.
13D/G row: Bain Charger Holdings, L.P.
Showing 1-8 of 50 holder rows.
Quick read
Bain Charger Holdings, L.P. leads the comparable SEC ownership view at 43%.
4 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bain Charger Holdings, L.P.'s linked filing trail.
Comparable ownership
Top 4
Bain Charger Holdings, L.P.
43%
FMR LLC
10%
PRICE T ROWE ASSOCIATES INC /MD/
8.5%
Endeavour Medtech Growth II LP
4.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bain Charger Holdings, L.P. |
13D/G
|
43%
Reported 13D/G
· 31 Dec 2025
|
$554,798,330
25,172,338 shares
|
-$40,705,389 | 31 Dec 2025 |
| FMR LLC |
13F
13D/G
Company
|
10%
Reported 13D/G
· 30 Sep 2025
|
$140,521,580
5,523,647 shares
|
— | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
Company · T. Rowe Price Associates, Inc.
|
8.5%
Reported 13D/G
· 30 Jun 2026
|
$126,410,000
4,968,900 shares
|
— | 30 Jun 2026 |
| Endeavour Medtech Growth II LP |
13D/G
|
4.2%
Reported 13D/G
· 31 Dec 2025
|
$53,974,682
2,448,942 shares
|
-$4,362,972 | 31 Dec 2025 |
| Jeffrey Lawrence Schwartz |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$640,746,441
25,186,574 shares
|
-$97,942 | 08 Sep 2026 |
| BAIN CAPITAL INVESTORS LLC |
13F
3/4/5
Company · 10%+ Owner
|
—
denominator unverified
|
$640,384,279
25,172,338 shares
|
— | 30 Jun 2026 |
| Christopher R. Gordon |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
—
27,019,225 shares
|
— | 06 Mar 2025 |
| Andera Partners |
13F
Company
|
—
denominator unverified
|
$69,417,594
2,728,679 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$8,770,857.
Buys
$199,800
Insiders: 1
Sells
$8,970,657
Insiders: 11
Net
-$8,770,857
Shares: -367,428
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 10,000
Shares: 377,428
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 246,928 | $0 | $5,997,691 | -$5,997,691 |
| 3-6 | 0 | 45,000 | $0 | $963,081 | -$963,081 |
| 6-9 | 10,000 | 45,000 | $199,800 | $988,814 | -$789,014 |
| 9-12 | 0 | 40,500 | $0 | $1,021,072 | -$1,021,072 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-15 of 15 reporting-owner rows connected to KESTRA MEDICAL TECHNOLOGIES, LTD.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
15
Largest Forms 3/4/5 holder
Jeffrey Lawrence Schwartz
Net 12M change
-$8,770,857
Latest report
30 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Jeffrey Lawrence Schwartz | Director, 10%+ Owner | $640,746,441 | -$97,942 | -0.02% | Mixed | 08 Sep 2026 |
| Brian Daniel Webster | President and Chief Executive Officer, Director | $44,098,709 | -$5,069,748 | -10% | Mixed | 17 Aug 2026 |
| Traci S. Umberger | General Counsel and Chief Adminstrative Officer, Director | $14,267,651 | -$879,065 | -5.8% | Mixed | 04 Aug 2026 |
| Alfred J. Ford Jr. | Chief Commercial Officer | $4,483,178 | -$793,664 | -15% | Mixed | 04 Aug 2026 |
| Vaseem Mahboob | Chief Financial Officer | $4,405,364 | -$1,271,235 | -22% | Mixed | 07 Aug 2026 |
| Raymond W. Cohen | Director | $1,604,278 | +$102,296 | +6.8% | Filing P/S | 30 Sep 2026 |
| Timothy P. Moran | Chief Business Officer | $1,576,430 | -$348,311 | -18% | Filing P/S | 30 Jul 2026 |
| Mary Kay Ladone | Director | $1,137,778 | -$98,464 | -8% | Mixed | 08 Sep 2026 |
| Conor Hanley | Director | $343,160 | -$143,779 | -30% | Mixed | 08 Sep 2026 |
| Elizabeth Kwo | Director | $342,401 | -$97,268 | -22% | Filing P/S | 21 Sep 2026 |
| Kevin C. Reilly | Director | $320,162 | -$73,677 | -19% | Mixed | 08 Sep 2026 |
| Christopher R. Gordon | Director, 10%+ Owner | Mixed | 06 Mar 2025 | |||
| Toby AuWerter | Director | Mixed | 06 Mar 2025 | |||
| Maxwell Bikoff | Director | Mixed | 06 Mar 2025 | |||
| BAIN CAPITAL INVESTORS LLC | 10%+ Owner | Mixed | 06 Mar 2025 |
Recent insider transactions for KESTRA MEDICAL TECHNOLOGIES, LTD.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Raymond W. Cohen | KMTS | Common Shares | Sale | -5.73% | $97,504 | $29.28 | -3,330 | 54,790 | 30 Sep 2026 | Direct |
| Elizabeth Kwo | KMTS | Common Shares | Sale | -22.1% | $97,268 | $24.26 | -4,010 | 14,116 | 21 Sep 2026 | Direct |
| Jeffrey Lawrence Schwartz | KMTS | Common Shares | Award | 102.8% | 7,217 | 14,236 | 09 Sep 2026 | Direct | ||
| Elizabeth Kwo | KMTS | Common Shares | Award | 66.2% | 7,217 | 18,126 | 09 Sep 2026 | Direct | ||
| Raymond W. Cohen | KMTS | Common Shares | Award | 14.2% | 7,217 | 58,120 | 09 Sep 2026 | Direct | ||
| Conor Hanley | KMTS | Common Shares | Award | 115.1% | 7,217 | 13,489 | 09 Sep 2026 | Direct | ||
| Kevin C. Reilly | KMTS | Common Shares | Award | 134.4% | 7,217 | 12,585 | 09 Sep 2026 | Direct | ||
| Mary Kay Ladone | KMTS | Common Shares | Award | 19.2% | 7,217 | 44,724 | 09 Sep 2026 | Direct | ||
| Jeffrey Lawrence Schwartz | KMTS | Common Shares | Sale | -35.7% | $97,942 | $25.18 | -3,890 | 7,019 | 08 Sep 2026 | Direct |
| Conor Hanley | KMTS | Common Shares | Sale | -47.6% | $143,779 | $25.25 | -5,694 | 6,272 | 08 Sep 2026 | Direct |
| Kevin C. Reilly | KMTS | Common Shares | Sale | -35.3% | $73,677 | $25.13 | -2,932 | 5,368 | 08 Sep 2026 | Direct |
| Mary Kay Ladone | KMTS | Common Shares | Sale | -9.44% | $98,464 | $25.20 | -3,908 | 37,507 | 08 Sep 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Sale | -3.16% | $412,180 | $27.48 | -15,000 | 460,215 | 17 Aug 2026 | Direct |
| Vaseem Mahboob | KMTS | Common Shares | Sale | -30.2% | $680,383 | $25.88 | -26,287 | 60,609 | 07 Aug 2026 | Direct |
| Alfred J. Ford Jr. | KMTS | Common Shares | Sale | -5.93% | $151,141 | $24.09 | -6,275 | 99,564 | 04 Aug 2026 | Direct |
| Vaseem Mahboob | KMTS | Common Shares | Sale | -7.45% | $172,635 | $24.68 | -6,995 | 86,896 | 04 Aug 2026 | Direct |
| Traci S. Umberger | KMTS | Common Shares | Sale | -1.8% | $86,073 | $24.04 | -3,580 | 195,825 | 04 Aug 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Sale | -9.85% | $1,272,588 | $24.52 | -51,900 | 475,215 | 04 Aug 2026 | Direct |
| Timothy P. Moran | KMTS | Common Shares | Sale | -3.46% | $56,551 | $23.76 | -2,380 | 66,345 | 03 Aug 2026 | Direct |
| Alfred J. Ford Jr. | KMTS | Common Shares | Sale | -11% | $311,118 | $23.90 | -13,015 | 105,839 | 03 Aug 2026 | Direct |
| Vaseem Mahboob | KMTS | Common Shares | Sale | -5.43% | $128,312 | $23.80 | -5,391 | 93,891 | 03 Aug 2026 | Direct |
| Traci S. Umberger | KMTS | Common Shares | Sale | -3.67% | $181,062 | $23.86 | -7,590 | 199,405 | 03 Aug 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Sale | -2.41% | $311,424 | $23.92 | -13,017 | 527,115 | 03 Aug 2026 | Direct |
| Timothy P. Moran | KMTS | Common Shares | Sale | -11.3% | $198,001 | $22.61 | -8,759 | 68,725 | 31 Jul 2026 | Direct |
| Alfred J. Ford Jr. | KMTS | Common Shares | Sale | -6.81% | $196,284 | $22.61 | -8,681 | 118,854 | 31 Jul 2026 | Direct |
| Vaseem Mahboob | KMTS | Common Shares | Sale | -8.16% | $199,344 | $22.61 | -8,817 | 99,282 | 31 Jul 2026 | Direct |
| Traci S. Umberger | KMTS | Common Shares | Sale | -4.06% | $197,837 | $22.60 | -8,752 | 206,995 | 31 Jul 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Sale | -1.63% | $202,260 | $22.60 | -8,948 | 540,132 | 31 Jul 2026 | Direct |
| Timothy P. Moran | KMTS | Common Shares | Sale | -5.05% | $93,758 | $22.77 | -4,117 | 77,484 | 30 Jul 2026 | Direct |
| Alfred J. Ford Jr. | KMTS | Common Shares | Sale | -4.45% | $135,121 | $22.76 | -5,936 | 127,535 | 30 Jul 2026 | Direct |
| Vaseem Mahboob | KMTS | Common Shares | Sale | -3.55% | $90,561 | $22.75 | -3,980 | 108,099 | 30 Jul 2026 | Direct |
| Traci S. Umberger | KMTS | Common Shares | Sale | -2.66% | $133,892 | $22.74 | -5,887 | 215,747 | 30 Jul 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Sale | -1.41% | $178,531 | $22.72 | -7,857 | 549,080 | 30 Jul 2026 | Direct |
| Timothy P. Moran | KMTS | Common Shares | Award | 92.1% | 39,113 | 81,601 | 16 Jul 2026 | Direct | ||
| Alfred J. Ford Jr. | KMTS | Common Shares | Award | 78.8% | 58,832 | 133,471 | 15 Jul 2026 | Direct | ||
| Vaseem Mahboob | KMTS | Common Shares | Award | 64.9% | 44,118 | 112,079 | 15 Jul 2026 | Direct | ||
| Traci S. Umberger | KMTS | Common Shares | Award | 36.1% | 58,832 | 221,634 | 15 Jul 2026 | Direct | ||
| Brian Daniel Webster | KMTS | Common Shares | Sale | -2.62% | $336,609 | $22.44 | -15,000 | 556,937 | 15 Jul 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Award | 44.6% | 176,470 | 571,937 | 15 Jul 2026 | Direct | ||
| Timothy P. Moran | KMTS | Common Stock | Award | 0.54% | 227 | 42,488 | 30 Jun 2026 | Direct | ||
| Traci S. Umberger | KMTS | Common Stock | Award | 0.58% | 942 | 162,802 | 30 Jun 2026 | Direct | ||
| Brian Daniel Webster | KMTS | Common Shares | Sale | -3.65% | $312,142 | $20.81 | -15,000 | 395,467 | 15 Jun 2026 | Direct |
| Timothy P. Moran | KMTS | Common Shares | Award | 116.1% | 22,704 | 42,261 | 03 Jun 2026 | Direct | ||
| Alfred J. Ford Jr. | KMTS | Common Shares | Award | 51% | 25,227 | 74,639 | 03 Jun 2026 | Direct | ||
| Vaseem Mahboob | KMTS | Common Shares | Award | 59% | 25,227 | 67,961 | 03 Jun 2026 | Direct | ||
| Traci S. Umberger | KMTS | Common Shares | Award | 18.5% | 25,227 | 161,860 | 03 Jun 2026 | Direct | ||
| Brian Daniel Webster | KMTS | Common Shares | Award | 22.6% | 75,681 | 410,467 | 03 Jun 2026 | Direct | ||
| Brian Daniel Webster | KMTS | Common Shares | Sale | -4.29% | $314,329 | $20.96 | -15,000 | 334,786 | 15 May 2026 | Direct |
| Brian Daniel Webster | KMTS | Common Shares | Sale | -4.11% | $300,670 | $20.04 | -15,000 | 349,786 | 15 Apr 2026 | Direct |
| Raymond W. Cohen | KMTS | Common Shares | Purchase | 24.4% | $199,800 | $19.98 | 10,000 | 50,903 | 26 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.